Novedades Ayuda Acceso institucional

Buscar recursos académicos

Encontrá libros, artículos, revistas, tesis y otros recursos académicos. Buscá, elegí el resultado correcto y accedé al contenido.

Búsqueda avanzada
Qué reúne NODOVOX Discovery: catálogos institucionales, recursos electrónicos, revistas de acceso abierto, colecciones disponibles y enlaces de consulta académica.
medicina forense derecho revistas Open Access texto completo

Resultados

8 resultados encontrados.

Tipos de recurso: Libro electrónico Artículo Revista Tesis Capítulo
Búsqueda académica
Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy
Artículo
Material complementario disponible Artículo DOAJ
Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy
William J. Freeman et al · Frontiers Media S.A · 2026 · ISSN 1664-3224
IntroductionSystemic juvenile idiopathic arthritis-associated lung disease (sJIA-LD) is a rare, potentially fatal complication of sJIA, often accompanied by pulmonary hypertension (PHTN) and macrophage activation syndrom...
LCC LCC:Immunologic diseases. AllergyIdioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario
Abrir material Ficha bibliográfica
Comparative efficacy and safety of oral Chinese patent medicines combined with conventional therapy for coronary heart disease complicated by diabetes: a systematic review and network meta-analysis
Artículo
Material complementario disponible Artículo DOAJ
Comparative efficacy and safety of oral Chinese patent medicines combined with conventional therapy for coronary heart disease complicated by diabetes: a systematic review and network meta-analysis
Dan Han et al · Frontiers Media S.A · 2026 · ISSN 2297-055X
BackgroundCoronary heart disease (CHD) frequently coexists with diabetes mellitus (DM), resulting in a complex metabolic–vascular disorder with poor cardiovascular prognosis. Oral Chinese patent medicines (OCPMs) are w...
LCC TENDOkRpc2Vhc2VzIG9mIHRoZSBjaXJjdWxhdG9yeSAoQ2FyZGlvdmFzY3VsYXIpIHN5c3RlbQ~~Idioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario
Abrir material Ficha bibliográfica
Construction and validation of a prediction model for in-stent restenosis following coronary stent implantation during dual antiplatelet therapy
Artículo
Material complementario disponible Artículo DOAJ
Construction and validation of a prediction model for in-stent restenosis following coronary stent implantation during dual antiplatelet therapy
Zhuoyi Zhang et al · Frontiers Media S.A · 2026 · ISSN 2297-055X
ObjectivesIn-stent restenosis (ISR) is a serious complication that occurs after a percutaneous coronary intervention (PCI). This study aims to integrate thromboelastography (TEG) parameters, coagulation function, and cli...
LCC TENDOkRpc2Vhc2VzIG9mIHRoZSBjaXJjdWxhdG9yeSAoQ2FyZGlvdmFzY3VsYXIpIHN5c3RlbQ~~Idioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario
Abrir material Ficha bibliográfica
Persistent residual inflammatory risk at 1 month after contemporary PCI: rationale for routine hsCRP reassessment and dual-target therapy
Artículo
Material complementario disponible Artículo DOAJ
Persistent residual inflammatory risk at 1 month after contemporary PCI: rationale for routine hsCRP reassessment and dual-target therapy
Xinwang Gong et al · Frontiers Media S.A · 2026 · ISSN 1664-3224
Despite major advances in lipid-lowering therapy and stent technology, a substantial proportion of patients undergoing contemporary percutaneous coronary intervention (PCI) experience recurrent major adverse cardiovascul...
LCC LCC:Immunologic diseases. AllergyIdioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario
Abrir material Ficha bibliográfica
A randomized controlled trial of telemedicine and e-health interventions for the management of oral complications in oncology patients undergoing antineoplastic therapy
Artículo
Material complementario disponible Artículo DOAJ
A randomized controlled trial of telemedicine and e-health interventions for the management of oral complications in oncology patients undergoing antineoplastic therapy
Pinelopi Petropoulou et al · Frontiers Media S.A · 2026 · ISSN 2234-943X
BackgroundSevere oral complications during and after antineoplastic therapies, such as mucositis, fungal, viral, and bacterial infections, xerostomia, dysphagia, and jaw osteonecrosis, significantly impair oral health an...
LCC TENDOk5lb3BsYXNtcy4gVHVtb3JzLiBPbmNvbG9neS4gSW5jbHVkaW5nIGNhbmNlciBhbmQgY2FyY2lub2dlbnM~Idioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario
Abrir material Ficha bibliográfica
Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges
Artículo
Material complementario disponible Artículo DOAJ
Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges
Sirajunisa Talath et al · Frontiers Media S.A · 2026 · ISSN 2234-943X
The incidence and mortality rates of breast cancer are increasing, although improvements in traditional treatments, and it remains the most frequent cancer among women globally. The increasing demand for natural suppleme...
LCC TENDOk5lb3BsYXNtcy4gVHVtb3JzLiBPbmNvbG9neS4gSW5jbHVkaW5nIGNhbmNlciBhbmQgY2FyY2lub2dlbnM~Idioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario
Abrir material Ficha bibliográfica
Antibiotic use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database
Artículo
Acceso abierto Artículo DOAJ
Antibiotic use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database
Jia Yu et al · Frontiers Media S.A · 2026 · ISSN 1664-3224
BackgroundThe use of antibiotics may influence the efficacy and toxicity of immune checkpoint inhibitors (ICIs) by altering the gut microbiota. However, current evidence on the link between antibiotic use and immune-rela...
LCC LCC:Immunologic diseases. AllergyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access
Disponible en línea Ficha bibliográfica
The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review
Artículo
Acceso abierto Artículo DOAJ
The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review
Alexandru-Ioan Pîntea et al · Frontiers Media S.A · 2026 · ISSN 1663-9812
IntroductionPancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive and invasive malignancies, with limited response to the currently available systemic therapy options. Having a 5-year survival of 12%...
LCC LCC:Therapeutics. PharmacologyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access
Disponible en línea Ficha bibliográfica